- Home
- PCN vs TMCI Comparison
PCN vs TMCI Comparison
Compare PCN & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCN
- TMCI
- Stock Information
- Founded
- PCN 2001
- TMCI 2014
- Country
- PCN United States
- TMCI United States
- Employees
- PCN N/A
- TMCI N/A
- Industry
- PCN Investment Managers
- TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PCN Finance
- TMCI Health Care
- Exchange
- PCN Nasdaq
- TMCI Nasdaq
- Market Cap
- PCN 781.6M
- TMCI 649.1M
- IPO Year
- PCN N/A
- TMCI 2021
- Fundamental
- Price
- PCN $13.75
- TMCI $9.37
- Analyst Decision
- PCN
- TMCI Hold
- Analyst Count
- PCN 0
- TMCI 8
- Target Price
- PCN N/A
- TMCI $8.84
- AVG Volume (30 Days)
- PCN 218.7K
- TMCI 413.1K
- Earning Date
- PCN 01-01-0001
- TMCI 02-27-2025
- Dividend Yield
- PCN 9.73%
- TMCI N/A
- EPS Growth
- PCN N/A
- TMCI N/A
- EPS
- PCN N/A
- TMCI N/A
- Revenue
- PCN N/A
- TMCI $202,861,000.00
- Revenue This Year
- PCN N/A
- TMCI $13.27
- Revenue Next Year
- PCN N/A
- TMCI $8.61
- P/E Ratio
- PCN N/A
- TMCI N/A
- Revenue Growth
- PCN N/A
- TMCI 16.14
- 52 Week Low
- PCN $10.70
- TMCI $3.92
- 52 Week High
- PCN $14.48
- TMCI $14.82
- Technical
- Relative Strength Index (RSI)
- PCN 57.43
- TMCI 47.42
- Support Level
- PCN $13.66
- TMCI $9.69
- Resistance Level
- PCN $13.81
- TMCI $10.30
- Average True Range (ATR)
- PCN 0.07
- TMCI 0.45
- MACD
- PCN 0.01
- TMCI -0.16
- Stochastic Oscillator
- PCN 70.65
- TMCI 3.40
About PCN Pimco Corporate & Income Strategy Fund
PIMCO Corporate & Income Strategy Fund is a closed-end management investment company. Its objective is to seek high current income with capital appreciation as a secondary objective. It invests in corporate bonds and notes, non-agency mortgage-backed securities, asset-backed securities, short-term instruments, and others.
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals.